Table 3. Summary of clinical characteristics and findings of patients in our study.
| No. | Age (years) | Gender | Indication | MS (if known CD) | FC (μg/g) | SBCE findingsTotal time; GTT; SBTT (min) Findings | LS | MotilGI® report | TT (min)WBTT; GTT; SBTT | pH | MI (segmental) |
| 1 | 49 | M | Known CD | A2L1B1 | 60 | 546; 125; 205Single aphtha, poor views | 135 | Signal loss, long GTT of SBCE but not WMCs | 1667; 226; 141 | n/a | n/a |
| 2 | 37 | M | Known CD | A1 /2L1B1 | – | 516; 36; 242Blood in stomach,no mucosal inflammation | 0 | Generally prolonged transit times, poor motility | 6620; 2577; 288 | Gastric 1.4SB 7.2 | Gastric 16.75Duo 11.60SB 15.18Caecum 12.19 |
| 3 | 58 | F | Known CD | A3L1B1 | 590 | 683; 28; 552Gastric residue + + + , lymphangiectasias, mucosal erythema, ?stenosis x 2 | 3810 | Prolonged transit time | 7161; 1096; 638 | n/a | Gastric – Duo 12.51SB – Caecum 14.17 |
| 4 | 34 | F | Known CD | A2L3B1 p | Insuff | n/a | n/a | High gastric pH, ?pt on PPI | 2686; 867; 240 | Gastric 5.4SB 7.1 | Gastric 16.3Duo 9.89SB 16.24Caecum 14.72 |
| 5 | 72 | F | Known CD | A?L1B1 | Insuff | 857; 77; 252Distortion of folds,Lymphangiectasias, mucosal erythema, multiple aphthae | 5160 | Generally low motility | 1956; 798; 447 | Gastric 1.1SB 7.2 | Gastric 14.65Duo 9.19SB 14.16Caecum 12.00 |
| 6 | 51 | M | Known CD | A2L3B1 | 80 | 436; 65; 342aphtha x1, reticulonodular mucosal pattern | 450 | Signal loss | 1609; n/a; n/a | n/a | n/a |
| 7 | 37 | F | Known CDColectomy + ileoanal pouch | A2L3B1 | 290 | 384; 19; n/aNormal to pouch | 0 | WMC not done – dropout | n/a | n/a | n/a |
| 8 | 40 | F | Known CDPancolectomy + ileostomy | A2L3B1 | – | 410; 10; 254Gastritis, poor views | 0 | Signal loss, rapid transit time | 808*; 233; n/a | n/a | n/a |
| 9 | 66 | F | ?CD | NA | 970 | 369; n/a; n/aGastric retention, pyloric stenosis | n/a | Data loss, CR | n/a | n/a | n/a |
| 10 | 58 | M | ?CD | – | 320 | 517; 31; 169Mucosal oedema & denudation, ? enteropathy | 280 | Low motility, acidic SB | 1312; 167; 192 | Gastric 1.2SB 6.4 | Gastric 11.58Duo 11.41SB 15.98Caecum 14.61 |
| 11 | 36 | M | ?CD | – | 110 | 234; 33; 188Mucosal cobblestone, Several aphthae | 450 | Signal loss but normal transit of WMC | n/a | n/a | n/a |
| 12 | 23 | F | ?CD | – | 300 | 439; 14; 327Aphthae x 2 | 450 | High gastric pH, very long colon transit | 6650; 142; 252 | Gastric 3.7SB 6.6 | Gastric 10.26Duo 11.31SB 15.77Caecum 11.97 |
Abbreviations: CD, Crohn’s Disease; CR, capsule retention; Duo, duodenum; FC, fecal calprotectin; GTT, gastric transit time; LS, Lewis score; MI, motility index; MS, Montreal score; PPI, proton pump inhibitor; SB, small bowel; SBCE, small-bowel capsule endoscopy; SBTT, small-bowel transit time; TT, transit times; WBTT, whole-bowel transit time; WMC, wireless motility capsule
*
In the case of patient 8, WBTT was taken as time to excretion of capsule in ileostomy.